Jonathan F. Anker
- Molecular Biology
- Oncology top 5%
- Cancer Research top 10%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Young Kwang ChaeSarki A. AbdulkadirFrancis J. GilesSarita AgteWade T. IamsHanlin MokKenji UnnoMarcelo Cruz
- Topics
- Cancer Immunotherapy and Biomarkers (16 papers)Bladder and Urothelial Cancer Treatments (8 papers)Cancer Genomics and Diagnostics (6 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Jonathan F. Anker
30 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Molecular Biology 617
- Oncology 519
- Cancer Research 251
- Immunology 233
- Pulmonary and Respiratory Medicine 227
Countries citing papers authored by Jonathan F. Anker
This map shows the geographic impact of Jonathan F. Anker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan F. Anker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan F. Anker more than expected).
Fields of papers citing papers by Jonathan F. Anker
This network shows the impact of papers produced by Jonathan F. Anker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan F. Anker. The network helps show where Jonathan F. Anker may publish in the future.
Co-authorship network of co-authors of Jonathan F. Anker
This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan F. Anker. A scholar is included among the top collaborators of Jonathan F. Anker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan F. Anker. Jonathan F. Anker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 7 | |
| 5 | 11 | |
| 6 | 15 | |
| 7 | 15 | |
| 8 | 77 | |
| 9 | 55 | |
| 10 | Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapybreakdown → | 302 |
| 11 | 44 | |
| 12 | 2 | |
| 13 | 7 | |
| 14 | 198 | |
| 15 | 80 | |
| 16 | 18 | |
| 17 | 32 | |
| 18 | 2 | |
| 19 | 22 | |
| 20 | 2 |
About Jonathan F. Anker
Jonathan F. Anker is a scholar working on Oncology, Cancer Research and Immunology, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Oncology (519 citations), Cancer Research (251 citations) and Immunology (233 citations). Jonathan F. Anker has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Young Kwang Chae, Sarki A. Abdulkadir, Francis J. Giles, Sarita Agte, Wade T. Iams, Hanlin Mok, Kenji Unno, Marcelo Cruz, Barbara Lysy and Vinay Sagar. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.